共 50 条
- [31] Stereotactic Body Radiation Therapy With or Without Transarterial Chemoembolization Versus Transarterial Chemoembolization Alone in Early-Stage Hepatocellular Carcinoma: A Systematic Review and Meta-Analysis [J]. Journal of Gastrointestinal Cancer, 2023, 54 : 1058 - 1070
- [32] Better survival after stereotactic body radiation therapy following transarterial chemoembolization in nonresectable hepatocellular carcinoma: A propensity score matched analysis [J]. SURGICAL ONCOLOGY-OXFORD, 2019, 28 : 228 - 235
- [33] Efficacy of Liver Stereotactic Body Radiation Therapy as Primary Treatment or Following Transarterial Chemoembolization (TACE) in Patients With HCC [J]. INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2016, 96 (02): : E176 - E177
- [34] Transarterial Chemoembolization with Drug-Eluting Beads vs. Stereotactic Body Radiation Therapy for Hepatocellular Carcinoma: Outcomes from a Multicenter Randomized Phase II Trial [J]. INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2022, 114 (03): : S104 - S105
- [39] The Treatment Results and Dosimetric Analysis of Stereotactic Body Radiation Therapy (SBRT) With Transarterial Chemoembolization (TACE) for Hepatocellular Carcinoma (HCC) [J]. INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2012, 84 (03): : S326 - S326
- [40] A Phase I Trial Evaluating Stereotactic Body Radiation Therapy to Induce Hyperemia in Combination with Transarterial Chemoembolization for Hepatocellular Carcinoma [J]. INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2019, 105 (01): : S208 - S208